CAP2 and infection: The Cap2-neutralizing epitope inserted into pCap3-Cap2E serves as an immunodominant determinant, suggesting that the chimeric-neutralizing epitopes of pCap3-Cap2E VLPs are capable of enhancing broad immune responses, highlighting their potential effectiveness as vaccine components against PCV2 and PCV3 infections.